Product Description
BevaciRel 100 mg 4 ml Injection is an anticancer medicine that is used alone or in combination with other medicines for the treatment of various types of cancers such as colorectal cancer, glioblastoma multiforme, renal cell carcinoma, cervical cancer, ovarian cancer, etc.
Mechanism and BenefitsBevacirel 100mg 4ml Bevacizumab Injection targets and inhibits VEGF, a signaling protein that stimulates blood vessel formation in tumors. By restricting this activity, the injection can slow tumor expansion and improve patient outcomes in certain cancers. Patients benefit from a targeted therapy aimed specifically at malignant blood supply mechanisms, which complements traditional chemotherapy.
Usage and Dosage GuidanceThis injection is administered intravenously by healthcare professionals, typically in cycles determined by your oncologist. Dosage and frequency depend on the type of cancer and the patient's health profile. Strict adherence to recommended dosing schedules is essential to optimize therapeutic results and minimize side effects.
Storage and Handling ProtocolBevacirel should always be stored in a cool, dry environment away from direct sunlight. Proper storage preserves its efficacy and safety until the moment of use. The injection must only be handled and administered by trained medical staff to ensure proper dosing and reduce risks associated with inappropriate use.
FAQ's of Bevacirel 100mg 4ml Bevacizumab Injection:
Q: How does Bevacirel 100mg 4ml Bevacizumab Injection work in cancer treatment?
A: Bevacirel contains bevacizumab, which targets and inhibits VEGF-a key protein involved in the growth of new blood vessels in tumors. By blocking VEGF, the injection deprives cancerous cells of necessary nutrients, helping to slow tumor growth.
Q: What are the benefits of using Bevacirel 100mg 4ml for cancer therapy?
A: The main benefit of Bevacirel is its targeted approach, which focuses on restricting blood supply to tumors. This targeted therapy can enhance outcomes in eligible cancer patients, often in conjunction with or following chemotherapy.
Q: When and how should Bevacirel Injection be administered?
A: Bevacirel 100mg 4ml is administered intravenously, strictly under the supervision of qualified healthcare professionals. The timing and frequency depend on your oncologist's recommendations and the specific cancer type being treated.
Q: Where should Bevacirel Injection be stored to maintain effectiveness?
A: This injection must be kept in a cool, dry place, away from heat and direct sunlight, to preserve its potency and safety until administration.
Q: What is the process for exporting or supplying Bevacirel 100mg 4ml Bevacizumab Injection from India?
A: Authorized exporters, suppliers, and traders in India handle the regulatory and logistical processes for international supply, ensuring compliance with medical and safety standards of the destination country.
Q: Who is recommended to use Bevacirel 100mg 4ml Bevacizumab Injection?
A: This injection is prescribed for patients diagnosed with specific types of cancers for which bevacizumab is indicated. It should be used only on a licensed physician's recommendation after careful health assessment.